Plasma iga antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes

Annals of Medicine

Volumn 45, Issue 8, 2013, Pages 501-510

  Vehkala, Lauri ^a,b   Ukkola, Olavi ^a,b   Kesäniemi, Y Antero ^a,b   Kähönen, Mika ^c   Nieminen, Markku S ^d   Salomaa, Veikko ^e   Jula, Antti ^e   Hörkkö, Sohvi ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

CRP; Glucose metabolism; Oxidized LDL; TNF

Indexed keywords

ACETALDEHYDE; ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; IMMUNOGLOBULIN A ANTIBODY; INSULIN; INTERLEUKIN 6; MALONALDEHYDE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDIATOR; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACETALDEHYDE; ADIPONECTIN; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOGLOBULIN A; INSULIN; INTERLEUKIN-6; LINEAR MODELS; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887583809     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2013.841322     Document Type: Article

References (55)

1. Shoelson SE, Herrero L, Naaz A. Obesity, infl ammation, and insulin resistance. Gastroenterology. 2007; 132: 2169-80 (Pubitemid 46693756)
2. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes. 2004; 53: 1412-17 (Pubitemid 38697650)
3. H olvoet P , M ertens A , V erhamme P , B ogaerts K , B eyens G , V erhaeghe R , et al . Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease . Arterioscler Th romb Vasc Biol. 2001 ; 21 : 844-8 . (Pubitemid 32448777)
4. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al . Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study . Arterioscler Th romb Vasc Biol. 2003 ; 23 : 434-9 . (Pubitemid 36337219)
5. Weinbrenner T, Schroder H, Escurriol V, Fito M, Elosua R, Vila J, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women . Am J Clin Nutr. 2006 ; 83 : 30-5 ; quiz 181-2
6. Hansson GK, Hermansson A. Th e immune system in atherosclerosis . Nat Immunol. 2011; 12: 204-12
7. Holvoet P, Lee DH, Steff es M, Gross M, Jacobs DR Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 2008; 299: 2287-93 (Pubitemid 351724395)
8. Karvonen J, Paivansalo M, Kesaniemi YA, Horkko S. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis . Circulation. 2003 ; 108 : 2107-12 . (Pubitemid 37337587)
9. S mpi M, Ukkola O, Paivansalo M, Kesaniemi YA, Binder CJ, Horkko S . Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J Am Coll Cardiol. 2008; 52: 1370-8
10. S mpi M, Veneskoski M, Ukkola O, Kesaniemi YA, Horkko S. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism. J Clin Endocrinol Metab. 2010; 95: 2467-75
11. Subbanagounder G, Wong JW, Lee H, Faull KF, Miller E, Witztum JL, et al . Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta . J Biol Chem . 2002 ; 277 : 7271-81 . (Pubitemid 34953120)
12. Frostegard J, Huang YH, Ronnelid J, Schafer-Elinder L. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. Arterioscler Th romb Vasc Biol. 1997; 17: 963-8 (Pubitemid 27209276)
13. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice . Cardiovasc Res. 2008 ; 79 : 360-76 .
14. Lappalainen J, Lindstedt KA, Oksjoki R, Kovanen PT. OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells. Atherosclerosis. 2011; 214: 357-63 .
15. Saad AF, Virella G, Chassereau C, Boackle RJ, Lopes-Virella MF. OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages . J Lipid Res. 2006 ; 47 : 1975-83 . (Pubitemid 44401985)
16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995; 95: 2409-15
17. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X . Diabetologia. 1997 ; 40 : 1286-92 . (Pubitemid 27469668)
18. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. Th e hormone resistin links obesity to diabetes . Nature. 2001 ; 409 : 307-12 . (Pubitemid 32151228)
19. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specifi c gene dysregulated in obesity . J Biol Chem. 1996; 271: 10697-703 (Pubitemid 26145805)
20. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991; 11: 81-128 (Pubitemid 121003917)
21. Tuma DJ, Th iele GM, Xu D, Klassen LW, Sorrell MF. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration . Hepatology. 1996 ; 23 : 872-880 . (Pubitemid 26112004)
22. Th iele GM, Tuma DJ, Willis MS, Miller JA, McDonald TL, Sorrell MF, et al . Soluble proteins modifi ed with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant . Alcohol Clin Exp Res. 1998 ; 22 : 1731-9 . (Pubitemid 28536164)
23. Willis MS, Th iele GM, Tuma DJ, Klassen LW. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated . Int Immunopharmacol. 2003; 3: 1381-99 (Pubitemid 37025719)
24. Hill GE, Miller JA, Baxter BT, Klassen LW, Duryee MJ, Tuma DJ, et al. Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular infl ammatory injury . Atherosclerosis. 1998; 141: 107-16 (Pubitemid 28539421)
25. Duryee MJ, Klassen LW, Schaff ert CS, Tuma DJ, Hunter CD, Garvin RP, et al . Malondialdehyde-acetaldehyde adduct is the dominant epitope aft er MDA modifi cation of proteins in atherosclerosis . Free Radic Biol Med. 2010; 49: 1480-6
26. Aromaa A, Koskinen S. Health and functional capacity in Finland: baseline results of the Health 2000 health examination survey . Helsinki: Kansanterveyslaitos; 2004
27. Sipila K, Koivistoinen T, Moilanen L, Nieminen T, Reunanen A, Jula A, et al . Metabolic syndrome and arterial stiff ness: the Health 2000 Survey . Metabolism. 2007; 56: 320-6
28. Kunnari AM, Savolainen ER, Ukkola OH, Kesaniemi YA, Jokela MA . Th e expression of human resistin in diff erent leucocyte lineages is modulated by LPS and TNFalpha . Regul Pept. 2009 ; 157 : 57-63 .
29. . L ow plasma adiponectin concentration is an indicator of the metabolic syndrome . Eur J Endocrinol. 2006 ; 155 : 745-50 .
30. Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, et al . Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities . Clin Exp Immunol. 2008 ; 151 : 42-50 . (Pubitemid 350230994)
31. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR , et al . A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990; 322: 882-9 (Pubitemid 20108377)
32. Kelly AS, Jacobs DR Jr, Sinaiko AR, Moran A, Steff en LM, Steinberger J. Relation of circulating oxidized LDL to obesity and insulin resistance in children. Pediatr Diabetes. 2010; 11: 552-5
33. Vasankari T, Fogelholm M, Kukkonen-Harjula K, Nenonen A, Kujala U, Oja P , et al . Reduced oxidized low-density lipoprotein aft er weight reduction in obese premenopausal women . Int J Obes Relat Metab Disord. 2001; 25: 205-11
34. Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, et al . Increased low-density lipoprotein oxidation and impaired highdensity lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation. 2003; 107: 1640-6 . (Pubitemid 36397333)
35. Suzuki K, Ito Y, Ochiai J, Kusuhara Y, Hashimoto S, Tokudome S, et al. Relationship between obesity and serum markers of oxidative stress and infl ammation in Japanese. Asian Pac J Cancer Prev. 2003; 4: 259-66
36. M utlu-Turkoglu U , O ztezcan S , T elci A , O rhan Y , A ykac-Toker G , S ivas A , et al . An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med. 2003; 2: 171-4 (Pubitemid 36313182)
37. Fagerberg B, Bokemark L, Hulthe J. Th e metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men . Nutr Metab Cardiovasc Dis. 2001; 11: 227-35 (Pubitemid 33686212)
38. Wonisch W, Falk A, Sundl I, Winklhofer-Roob BM, Lindschinger M. Oxidative stress increases continuously with BMI and age with unfavourable profi les in males. Aging Male. 2012; 15: 159-65
39. Horkko S, Binder CJ, Shaw PX, Chang MK, Silverman G, Palinski W, et al . Immunological responses to oxidized LDL . Free Radic Biol Med. 2000 ; 28 : 1771-9 . (Pubitemid 30628664)
40. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX , et al . Oxidation-specifi c epitopes are dominant targets of innate natural antibodies in mice and humans . J Clin Invest. 2009 ; 119 : 1335-49 .
41. Su J, Georgiades A, Wu R, Th ulin T, de Faire U, Frostegard J. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension . Atherosclerosis. 2006; 188: 160-6 (Pubitemid 44160704)
42. Sjoberg BG, Su J, Dahlbom I, Gronlund H, Wikstrom M, Hedblad B, et al . Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men . Atherosclerosis. 2009 ; 203 : 528-532 .
43. Tsimikas S, Willeit P, Willeit J, Santer P, Mayr M, Xu Q, et al. Oxidationspecifi c biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassifi cation of cardiovascular events . J Am Coll Cardiol. 2012; 60: 2218-29
44. Tuma DJ, Kearley ML, Th iele GM, Worrall S, Haver A, Klassen LW, et al . Elucidation of reaction scheme describing malondialdehydeacetaldehyde-protein adduct formation . Chem Res Toxicol. 2001 ; 14 : 822-32 . (Pubitemid 32661337)
45. Kharbanda KK, Todero SL, Shubert KA, Sorrell MF, Tuma DJ. Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells. Alcohol. 2001; 25: 123-8 (Pubitemid 34016038)
46. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and infl ammatory cytokines (AIR Study). Arterioscler Th romb Vasc Biol. 2002 ; 22 : 1162-7 . (Pubitemid 34764868)
47. H ulthe J , W ikstrand J , F agerberg B . R elationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study . Clin Sci (Lond). 2001 ; 100 : 371-8 . (Pubitemid 32324334)
48. Resch U, Tatzber F, Budinsky A, Sinzinger H. Reduction of oxidative stress and modulation of autoantibodies against modifi ed low-density lipoprotein aft er rosuvastatin therapy . Br J Clin Pharmacol. 2006 ; 61 : 262-74 . (Pubitemid 43382625)
49. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK . Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. 2005; 54: 2939-45 (Pubitemid 41401090)
50. W ang Z Y, B jorling D E. T umor necrosis factor-alpha induces expression and release of interleukin-6 by human urothelial cells . Infl amm Res. 2011 ; 60 : 525-32 .
51. Virella G, Atchley D, Koskinen S, Zheng D, Lopes-Virella MF; DCCT/ EDIC Research Group. Proatherogenic and proinfl ammatory properties of immune complexes prepared with purifi ed human oxLDL antibodies and human oxLDL. Clin Immunol. 2002; 105: 81-92 (Pubitemid 35222245)
52. Q in B , Q iu W , A vramoglu R K, A deli K . T umor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins . Diabetes. 2007; 56: 450-61.
53. Otten MA , van Egmond M . Th 53. e Fc receptor for IgA (FcalphaRI, CD89) . Immunol Lett. 2004; 92: 23-31
54. van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, et al . FcalphaRI-positive liver Kupff er cells: reappraisal of the function of immunoglobulin A in immunity . Nat Med. 2000 ; 6 : 680-5 . (Pubitemid 30398792)
55. Shoma S, Verkaik NJ, de Vogel CP, Hermans PW, van Selm S, Mitchell TJ, et al . Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins . Eur J Clin Microbiol Infect Dis. 2011; 30: 521-6.